Join Us at ESMO Breast 2021
We are showcasing MammaPrint® and BluePrint® genomic tests for comprehensive profiling of early-stage breast cancer.
Agendia’s activities at ESMO breast 2021:
Data Highlights – Oral Session
Title – 20-year benefit of endocrine therapy in premenopausal breast cancer patients by the 70-gene risk signature
Date – Saturday May 8th, 13:36-13:41
Speaker – A. Johansson (Stockholm, Sweden)
#IAMHERE
An intimate portrait series that illustrates the essence of 50 people who have been touched by breast cancer – Click here to view campaign.
Virtual Booth
Visit our virtual booth for more information and to speak with a member of our team.
